2. Academic Validation
  3. Novel Azepinoindoles as 5‑HT2C Agonists for Treating Depression, Drug Addiction, Alcoholism, PTSD, and Neuropathic Pain

Novel Azepinoindoles as 5‑HT2C Agonists for Treating Depression, Drug Addiction, Alcoholism, PTSD, and Neuropathic Pain

  • ACS Med Chem Lett. 2025 Jul 28;16(8):1507-1508. doi: 10.1021/acsmedchemlett.5c00426.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
PMID: 40832530 DOI: 10.1021/acsmedchemlett.5c00426
Abstract

Provided herein are novel azepinoindoles as 5-HT2C agonists, pharmaceutical compositions, use of such compounds in treating depression, drug addiction, alcoholism, post-traumatic stress disorder (PTSD), and neuropathic pain, and processes for preparing such compounds.

Figures
Products